Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Progress Biotech is a Netherlands-based biotechnology company specializing in the development and supply of high-quality, algae-based Omega-3 fatty acids, specifically docosahexaenoic acid (DHA). The company utilizes advanced fermentation technology to produce sustainable, vegan-friendly alternatives to fish oil, catering to the infant formula, dietary supplement, and functional food markets. Their product portfolio includes high-concentration DHA oils and powders that are free from environmental contaminants often found in marine sources. Progress Biotech focuses on providing scalable, sustainable nutritional solutions while maintaining rigorous quality standards for global distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Progress Biotech.